Human Health and Potential (HHP)

A*STAR researchers have developed a microneedle patch technology that can deliver drugs and vaccines more effectively and with minimal invasiveness.

A new cellular model of colorectal cancer helps identify high-risk subtypes likely to resist standard treatments and proliferate in response.

By examining how soy protein concentrates affect protein fibrous texture, scientists address existing quality control issues faced by meat-alternative manufacturers.

Nanopore sequencing and a self-enhancing AI model team up to enable a faster and more accurate method for reading synthetic genes.

A*STAR researchers develop a smarter delivery system for mRNA vaccines that boosts their targeting abilities and biological safety.

A tri-enzyme delivery platform restores biochemical balance and promotes healing in skin wounds. 

A unique RNA structure shared across SARS-CoV-2 variants may contribute to viral fitness, offering a potential target for new antiviral treatments.

Comparing hypothalamic networks in zebrafish and mice reveals evolutionarily conserved neuronal pathways that regulate appetite across vertebrates.

A new light-sensitive hydrogel platform that models human tissue elasticity reveals how ageing cells react to a changing environment.

Enhanced RNA-based profiling techniques reveal the outsized metabolic impacts of small microbial populations across the human body surface.

An anti-hypertension drug could potentially be repurposed as a more affordable treatment for liver cancer.

The largest RNA language model to date helps researchers uncover the hidden roles played by non-coding RNA sequences in our cells.